Ambesi, Anthony <br/><br/>
Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.  [electronic resource] 

 -  Molecular cancer research : MCR  Feb 2009 
 - 255-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1541-7786 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-08-0195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Angiostatic Proteins--pharmacology<br/>Cell Movement<br/>Cells, Cultured<br/>Endothelium, Vascular--cytology<br/>ErbB Receptors--genetics<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Fibronectins--pharmacology<br/>GTP-Binding Protein alpha Subunits, Gi-Go--metabolism<br/>Humans<br/>Immunoblotting<br/>Immunoprecipitation<br/>Lysophospholipids--antagonists & inhibitors<br/>Microcirculation--physiology<br/>Peptide Fragments--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Receptors, G-Protein-Coupled--metabolism<br/>Receptors, Vascular Endothelial Growth Factor--genetics<br/>S Phase--drug effects<br/>Signal Transduction--drug effects<br/>Skin--blood supply<br/>rho-Associated Kinases--metabolism